Quick Heal Technologies Ltd

Q1 FY24IT - Software

Quick Heal Technologies Q1 FY24: Revenue ₹51.44 Cr, PAT ₹0.18 Cr

Q1 FY24 investor presentation: what the company reported on revenue, margins and projects.

Price₹148

Market cap₹827 Cr

Updated24 Sept 2026

Read4 min read

Based on Quick Heal Technologies Ltd's Q1 FY24 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.

The short version

Q1 FY24 total revenue: ₹51.44 crores (Consolidated); down from ₹61.08 crores in Q1 FY23 - Year-on-year revenue decline: approximately 15.8% - Consumer revenue Q1 FY24: ₹27.4 crores; Enterprise revenue Q1 FY24: ₹26.5 crores (both gross, before sales incentives) - Revenue decline primarily due to temporary headwinds in the consumer business - Enterprise segment shows sustainable growth and outperformed market growth rates, expanding in international markets (LATAM, Africa) - Q1 FY24 EBITDA at -₹15.1 crores vs. Q1-FY24 EBITDA: ₹(15.08) crores, down from ₹1.05 crores in Q1-FY23 (YoY drop).

From Quick Heal Technologies Ltd's Q1 FY24 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

Q1 FY24 total revenue: ₹51.44 crores (Consolidated); down from ₹61.08 crores in Q1 FY23
Year-on-year revenue decline: approximately 15.8%
Consumer revenue Q1 FY24: ₹27.4 crores; Enterprise revenue Q1 FY24: ₹26.5 crores (both gross, before sales incentives)
Revenue decline primarily due to temporary headwinds in the consumer business
Enterprise segment shows sustainable growth and outperformed market growth rates, expanding in international markets (LATAM, Africa)
Q1 FY24 EBITDA at -₹15.1 crores vs. ₹1.1 crores in Q1 FY23; PAT declined from ₹0.2 crores to -₹12.8 crores

2 more points management made on revenue & sales performance

Profitability & Margins

Q1-FY24 EBITDA: ₹(15.08) crores, down from ₹1.05 crores in Q1-FY23 (YoY drop).
Q1-FY24 EBITDA Margin: -29.32%, down from 1.72% in Q1-FY23.
Q1-FY24 Profit After Tax (PAT): ₹(12.76) crores, down from ₹0.18 crores in Q1-FY23.
Q1-FY24 PAT Margin: -24.81%, down from 0.29% in Q1-FY23.

2 more points management made on profitability & margins

See what Quick Heal Technologies Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The investor presentation does not explicitly mention any capital expenditure (capex), capacity expansion, or new plant/project details including amounts, status, or timelines. The focus is on business segments, financials, R&D spending, market growth, and future growth strategies such as global expansion and enterprise solutions, but no specific capex or new plant/project investments are detailed.

Top-ranked in IT - Software

Ranked on what management guided this quarter

5x potential

1Workmates Core2cloud Solution Ltd₹536 Cr

Rev 1Mar 1

2Virtual Galaxy₹361 Cr

Rev 1Mar 3

3₹194 Cr

Rev 2Mar 1

4₹140 Cr

Rev 2Mar 1

5₹2.0K Cr

Rev 2Mar 2

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The investor presentation does not mention any fundraising through debt or equity.
There is no information provided about a change in borrowings or net debt.
The presentation primarily focuses on financial performance, operational highlights, business segments, future outlook, and contact details.

2 more points management made on fundraising & capital structure

See what Quick Heal Technologies Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The investor presentation does not explicitly report any details on order book, order inflow, or pending orders. There is no mention or data related to these metrics in the provided slides or textual content. The presentation primarily focuses on: - Financial performance (revenue, EBITDA, PAT). - Business segments (Consumer and Enterprise). - Growth outlook and market positioning.

2 more points management made on order book & pipeline

Quick Heal Technologies Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹49 Cr, net loss ₹20 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Quick Heal Tech's management said in earlier quarters

Compare:vs Tata Consultancy Services Ltd vs Infosys Ltd vs HCL Technologies Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Quick Heal Technologies Ltd Q1 FY24 results?

What is Quick Heal Technologies Ltd share price analysis?

Quick Heal Technologies Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹827 Cr. Investors should review the full earnings analysis for detailed insights.

Is Quick Heal Technologies Ltd planning capital expenditure?

The investor presentation does not explicitly mention any capital expenditure (capex), capacity expansion, or new plant/project details including amounts, status, or timelines.

Keep Quick Heal Technologies Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.